Regenerative Product: AmnioShot™
Amniotic fluid is used in many orthopedic diseases that are resistant to standard techniques. AmnioShot™ is derived from the amniotic fluid of donated birth tissues and leverages the healing properties of amniotic fluid for clinical applications.
Lone Peak Biologics is thrilled to announce the latest addition to its industry-leading line of human biologics products: AmnioShot™. AmnioShot™ leverages the healing properties of amniotic fluid for clinical applications, and has proteins that are known to promote healing, and reduce or inhibit adhesion and infection in a number of scenarios, some of which include:
- Wounds
- Osteo-Arthritis, Tendinitis
- Osteogenesis
Amniotic fluid has been used in many orthopedic diseases that are resistant to standard techniques, and it is being explored extensively to develop innovative therapies for other conditions. Allogeneic amniotic fluid has been used in Achilles tendinosis and plantar fasciosis by incorporating the amniotic fluid allograft as a suspension tissue scaffold or matrix to assist in tendon and fascia repair.
Furthermore, amniotic fluid is known to have low immunogenicity and contains carbohydrates, proteins, lipids, lactate, pyruvate, electrolytes, enzymes, and hormones. Additionally, amniotic fluid contains anti-inflammatory and osteo-promotive agents such as hyaluronic acid, epidermal growth factors (EGF)-angiogenic, transforming growth factors (TGFa and TGFb), and insulin-like growth factors (IGF).
Moreover, it can be used to support re-epithelialization, aid joints and connective tissues, and as a complement to bone grafts for spine fusions and other bone-healing procedures. Studies on the potential of products like these in regenerative medicine have yielded numerous results, and studies demonstrating the use of amniotic products have been largely successful.
Extraction of Amniotic Fluid … read more